Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_assertion type Assertion NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_head.
- NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_assertion description "[The combination of IFN-gamma and CaM antagonists, including tamoxifen, may be a potential therapeutic modality for cholangiocarcinoma and possibly other malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_provenance.
- NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_assertion evidence source_evidence_literature NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_provenance.
- NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_assertion SIO_000772 14578204 NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_provenance.
- NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_assertion wasDerivedFrom befree-20150227 NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_provenance.
- NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_assertion wasGeneratedBy ECO_0000203 NP279493.RAcKE4QWoSi673iOdWvdj5P7HbsId_1To8na2HuTqeWgc130_provenance.